Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

13.76

Margin Of Safety %

-41

Put/Call OI Ratio

0.24

EPS Next Q Diff

0.04

EPS Last/This Y

1.47

EPS This/Next Y

-0.36

Price

20

Target Price

17.8

Analyst Recom

2.53

Performance Q

72.33

Relative Volume

1.12

Beta

2.24

Ticker: TXG




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09TXG17.840.090.0511067
2025-12-10TXG17.550.090.2411324
2025-12-11TXG16.550.090.2511380
2025-12-12TXG15.450.100.2111387
2025-12-15TXG15.750.100.2611390
2025-12-16TXG15.70.100.1811438
2025-12-17TXG15.750.100.1011469
2025-12-18TXG16.010.100.0311447
2025-12-19TXG16.050.120.2711689
2025-12-22TXG16.950.150.228646
2025-12-23TXG16.540.153.598753
2025-12-26TXG16.490.220.669272
2025-12-29TXG16.140.220.099338
2025-12-30TXG16.280.220.049330
2025-12-31TXG16.320.221.069346
2026-01-02TXG16.60.220.769346
2026-01-05TXG18.340.220.609359
2026-01-06TXG19.320.240.039557
2026-01-07TXG20.010.240.089587
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09TXG17.8455.8-14.1-0.05
2025-12-10TXG17.5355.8-7.2-0.05
2025-12-11TXG16.5555.80.1-0.05
2025-12-12TXG15.4555.81.8-0.05
2025-12-15TXG15.7655.8-13.9-0.05
2025-12-16TXG15.7655.8-10.1-0.05
2025-12-17TXG15.7555.8-10.8-0.05
2025-12-18TXG16.0055.8-13.4-0.05
2025-12-19TXG16.0455.8-10.7-0.05
2025-12-22TXG16.8155.8-19.2-0.05
2025-12-23TXG16.5355.8-5.7-0.05
2025-12-26TXG16.5255.8-8.3-0.05
2025-12-29TXG16.1455.8-6.2-0.05
2025-12-30TXG16.2955.8-11.8-0.05
2025-12-31TXG16.3255.8-10.5-0.05
2026-01-02TXG16.6055.8-13.6-0.05
2026-01-05TXG18.3555.8-29.4-0.05
2026-01-06TXG19.3255.8-20.1-0.05
2026-01-07TXG20.0055.8-16.5-0.05
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09TXG-0.50-1.4313.84
2025-12-10TXG-0.50-1.4313.22
2025-12-11TXG-0.50-1.4313.22
2025-12-12TXG-0.50-1.4313.22
2025-12-15TXG-0.50-1.3713.21
2025-12-16TXG-0.50-1.3713.21
2025-12-17TXG-0.50-1.3713.21
2025-12-18TXG-0.50-1.3713.21
2025-12-19TXG-0.50-1.3713.21
2025-12-22TXG-0.50-1.3313.21
2025-12-23TXG-0.50-1.3313.21
2025-12-26TXG-0.50-1.3313.76
2025-12-29TXG-0.50-1.1513.76
2025-12-30TXG-0.50-1.1513.76
2025-12-31TXG-0.50-1.1513.76
2026-01-02TXG-0.50-1.1513.76
2026-01-05TXG-0.50-1.1513.76
2026-01-06TXG-0.50-1.1513.76
2026-01-07TXG-0.50-1.1513.76
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

-0.22

Avg. EPS Est. Current Quarter

-0.06

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

-0.5

Institutional Transactions

-1.15

Beta

2.24

Average Sales Estimate Current Quarter

156

Average Sales Estimate Next Quarter

142

Fair Value

11.85

Quality Score

40

Growth Score

37

Sentiment Score

96

Actual DrawDown %

90.4

Max Drawdown 5-Year %

-96.5

Target Price

17.8

P/E

Forward P/E

PEG

P/S

3.94

P/B

3.22

P/Free Cash Flow

34.64

EPS

-0.62

Average EPS Est. Cur. Y​

-0.05

EPS Next Y. (Est.)

-0.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.89

Relative Volume

1.12

Return on Equity vs Sector %

-36.8

Return on Equity vs Industry %

-25.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-16.5
10x Genomics, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 1306
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading